Piscataway, NJ, August 1, 2023–Camber Pharmaceuticals is pleased to announce the addition of Ibuprofen and Famotidine Tablets to its current portfolio.
Ibuprofen and Famotidine Tablets, a combination of the nonsteroidal anti-inflammatory drug (NSAID) ibuprofen and the histamine H2– receptor antagonist famotidine, is indicated for (1) the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis and (2) to decrease the risk of developing upper gastrointestinal ulcers, in patients who are taking ibuprofen for those indications.
Ibuprofen and Famotidine 800 mg/26.6mg Tablets are available in 90 count bottles.
To find out more about Ibuprofen and Famotidine Tablets please visit www.camberpharma.com.
